Transcutaneous Electrical Nerve Stimulation for Labor Pain Control in Combination With Cardiotocography
1 other identifier
interventional
10
1 country
1
Brief Summary
Transcutaneous electrical nerve stimulation (TENS) is a non-invasive electro-physical modality used for several pain conditions including labor pain control. Despite several years of research, there is still no agreement within the literature regarding the selection of TENS parameters. It is aimed to investigate TENS1 alternating between 4 to 100 Hz compared to sham-TENS. The present study aims to evaluate TENS in combination with cardiotocography (CTG). The combination of TENS with CTG in a feedback-loop has not been reported in any studies before.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2021
CompletedFirst Posted
Study publicly available on registry
July 1, 2021
CompletedStudy Start
First participant enrolled
July 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2021
CompletedAugust 30, 2021
August 1, 2021
1 month
June 23, 2021
August 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Visual Analog scale (VAS)
10-cm pain intensity scale with 0 cm is no pain and 10 cm is unbearable pain. Decreased cm after baseline measurement indicates pain relief.
Baseline, 10 minutes post stimulation, 30 minutes post stimulation
Pain pressure threshold (PPT)
Pain sensitivity measurement also defined as the minimum pressure needed to evoke a pain response measured in kPa. Increased kPa after baseline measurement indicates pain relief.
Baseline, 10 minutes post stimulation, 30 minutes post stimulation
Secondary Outcomes (4)
Satisfaction of TENS
Right after last measurements of VAS & PPT
Experienced pain reduction
Right after last measurements of VAS & PPT
Interest in the use of TENS again
Right after last measurements of VAS & PPT
Recommend TENS to others
Right after last measurements of VAS & PPT
Study Arms (2)
TENS
EXPERIMENTALTENS with 4/100 Hz in frequency, 200 µs in pulse duration, and intensity individually adjusted.
Sham-TENS
SHAM COMPARATORSham with 100 Hz in frequency, 200 µs in pulse duration, and intensity below 5 mA.
Interventions
Eligibility Criteria
You may qualify if:
- Singleton pregnancy
- Vertex presentation
- Speak, read and understand Danish
You may not qualify if:
- Gestational age \< 37+0 weeks
- Gestational age \> to 41+6 weeks
- High-risk pregnancies (including risk factors: eclampsia, pre-eclampsia, diabetes, gestational diabetes, hypertension (above 140/90), and hypotension (below 90/60), Intrauterine growth restriction (IUGR), polyhydramnious, and oligohydramnious).
- Pre-gestational body mass index (BMI) above 40 kg/m2
- Use of fetal scalp-electrode during the experiment
- Use of pacemakers and other electronic implants
- Severe arrhythmia
- Present musculoskeletal illnesses (including myopathy and arthritis).
- Chronic pain within last 6 months (Pelvic girdle pain (PGP) to a mild degree (VAS 0-6 cm) is accepted in the experiment. Severe degree (VAS 6-10 cm) (e.g. bedridden or difficulty walking) especially within 24 hours before birth is excluded).
- Present/previous neurologic illnesses (including epilepsy, migraine, and sclerosis).
- Present medicated mental disorders (including dementia, personality disorders, bipolar, ADHD, and anxiety).
- Dermatological disorders (including skin allergy, tattoos or scars on the locations of electrodes)
- Use of other long-acting pain relief before the experiment (including Epidural, Morphine less than 16 hours before experiment), Acupuncture, Paracetamol (less than 8 hours before experiment), Cocktail (less than 8 hours before experiment), nitrous oxide (less than one hour before experiment), sterile water injection (less than two hours before experiment).
- Use of TENS 48 hours before the trial
- Drug addiction defined as the use of cannabis, opioids or other drugs.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aalborg Universitylead
- Centaflowcollaborator
Study Sites (1)
Region Hospital Gødstrup
Herning, 7400, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Parisa Gazerani, PhD
Aalborg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double-blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
June 23, 2021
First Posted
July 1, 2021
Study Start
July 9, 2021
Primary Completion
August 13, 2021
Study Completion
August 13, 2021
Last Updated
August 30, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The study protocol will also be published after the manuscript publication. Expected to be published after September 2021.
Study protocol and individual participant data will be available.